What is the comparative dosage of metoprolol (Beta-1 selective beta blocker) to nadolol (non-selective beta blocker) for patients requiring beta-blockade?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Comparative Dosing of Metoprolol and Nadolol for Beta-Blockade

Based on current guidelines, metoprolol is typically dosed at 50-200 mg twice daily (tartrate) or 50-200 mg once daily (succinate), while nadolol is dosed at 40-120 mg once daily for patients requiring beta-blockade. 1

Dosage Comparison Table

Beta-Blocker Selectivity Daily Dosage Range Frequency Maximum Daily Dose
Metoprolol tartrate Beta-1 100-400 mg Twice daily 400 mg
Metoprolol succinate Beta-1 50-200 mg Once daily 400 mg
Nadolol Non-selective 40-120 mg Once daily 320 mg

Key Differences

Pharmacological Properties

  • Metoprolol: Beta-1 selective blocker, which primarily affects cardiac receptors with less effect on bronchial and vascular beta-2 receptors 1
  • Nadolol: Non-selective beta blocker that affects both beta-1 and beta-2 receptors 1

Administration Frequency

  • Metoprolol tartrate: Requires twice-daily dosing due to shorter half-life 1
  • Metoprolol succinate: Extended-release formulation allows once-daily dosing 1
  • Nadolol: Longer half-life allows for once-daily dosing 1

Dosing Considerations

Metoprolol

  • Starting dose typically 25-50 mg twice daily for tartrate formulation 1
  • For extended-release (succinate), starting dose is usually 50 mg once daily 1
  • Titrate upward as needed and tolerated
  • Maximum daily dose is 400 mg for both formulations 1

Nadolol

  • Starting dose typically 40 mg once daily 1
  • Titrate upward as needed and tolerated
  • Maximum daily dose is 320 mg 1
  • Requires dose reduction in renal impairment 1

Clinical Applications and Precautions

Indications where either agent may be used:

  • Hypertension
  • Angina pectoris
  • Atrial fibrillation (rate control)
  • Post-myocardial infarction

Specific Considerations:

  • Respiratory disease: Metoprolol is preferred over nadolol in patients with reactive airway disease due to its beta-1 selectivity 1
  • Renal impairment: Nadolol requires dose adjustment in renal dysfunction 1
  • Frequency preference: Nadolol may offer better adherence with once-daily dosing 1

Common Precautions for Both:

  • Avoid abrupt cessation of either medication 1
  • Use caution in patients with:
    • AV block greater than first degree
    • Sinus node dysfunction
    • Decompensated heart failure
    • Cardiogenic shock
    • Hypotension

Potency Comparison

Based on comparative studies, nadolol demonstrates greater potency than metoprolol, with the following approximate equivalence 2:

  • Nadolol 40 mg ≈ Metoprolol 100-120 mg

This higher potency of nadolol should be considered when switching between these medications to maintain equivalent beta-blockade.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Comparison of four beta-blockers as assessed by 24-hour ECG recording.

Clinical pharmacology and therapeutics, 1986

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.